top of page

SPONSORS & EXHIBITORS 2024

Premier Sponsor |  Exhibitor

DHAC_stacked.jpg

Australian Department of Health

Dr Ben Polkinghorne, Director Communicable Disease Epidemiology and Surveillance Section
T: 02 6289 5170
W: www.health.gov.au

The mission of the Office of Health Protection and Response, in partnership with key stakeholders, is to protect the health of the Australian community through effective national leadership, coordination and regulation; and by building and sustaining the capacity and capability to prevent, prepare and respond to threats and risks to public health and safety arising from communicable diseases, natural disasters, acts of terrorism and other incidents.

Fellow Sponsor

Queensland_Government_logo.svg.png

Queensland Government

T: 02 6289 5170
W: www.health.qld.gov.au


Providing a world-class health system for all Queenslanders.

We’re over 100,000 strong, with more than 300 diverse career paths. We are a world-class healthcare system, with training, professional development and career support to take you further.

Associate Sponsor, Exhibitor & Immunisation Awards | GSK

Sam Young
Vaccines Marketing Associate
A: Level 3, 436 Johnston Street Abbotsford VIC 3067
E: sam.p.young@gsk.com

W: www.gsk.com/en-gb/

 

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in vaccines and medicines development. We focus on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.

Associate Sponsor, Exhibitor & Feery Oration Sponsor | CSL Seqirus

CSLSeqirus_RGB_Highres_M01.png

Leonie Loyer
Director Government and In-licensed Vaccines
A: 655 Elizabeth Street Melbourne VIC 3000

E: Leonie.loyer@seqirus.com

W: www.cslseqirus.com.au 

 

CSL Seqirus is part of CSL Limited. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. In Australia, CSL Seqirus operates the only local manufacturing facility for seasonal and pandemic influenza vaccine and produces a range of unique medicines in the national interest including antivenoms and the world’s only human vaccine for Q fever. The company also in-licenses a broad range of paediatric and adult vaccines and specialty pharmaceutical products to help meet the needs of Australian public health.

Associate Sponsor & Exhibitor | Pfizer

Pfizer logo.png

Nathan Dallimore
A: Level 15, 151 Clarence St Sydney, NSW, 2000

W: www.pfizer.com.au

Breakthroughs that change patients’ lives™


At Pfizer, we apply science and our global resources to improve health and wellbeing at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of innovative medicines, with a diversified global healthcare portfolio, including biologic and small molecule medicines and vaccines.
Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare.
For more information, visit:
www.pfizer.com.au

Associate Sponsor & Exhibitor | MSD

MSD logo.png

Daniel Barnaby
Brand Manager - Vaccines at MSD Australia & New Zealand
A: Macquarie Park, NSW, 2000

W: www.msd-australia.com.au

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines.  We aspire to be the premier research-intensive biopharmaceutical company in the world - and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals.  We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Twitter, LinkedIn and YouTube.

Associate Sponsor & Exhibitor | Novavax & Biocelect

Novavax & Biocelect combined logo 2023-side by side.jpg

Emily Herz
Sales & Marketing Associate
A: Level 4, 143 Macquarie Street Sydney, NSW 2000
T: 0434 649 749
W: www.biocelect.com

W: www.novavax.com

 

Novavax is a US-based biotechnology company focused on the development of innovative vaccines that leverage our proprietary recombinant nanoparticle technology that may help prevent many infectious diseases.  Our platform has the potential to produce highly immunogenic antigens, enabling the production of vaccines to respond to known and emerging disease threats.

Biocelect Pty Ltd is a privately owned, full-service Australian pharmaceutical company working with local and overseas partners to bring critical pharmaceutical products and medical technology solutions to the Australian market. Our priority areas include infectious diseases, specialty care and in-vitro diagnostics. In 2020, Biocelect was appointed the Australian and New Zealand sponsor for the Novavax COVID-19 Vaccine.  We are proud to play an important part in our Governments’ COVID-19 management plans

Associate Sponsor & Exhibitor | Sanofi

Sanofi Logo JPG.jpg

Monica Jones
Commercial Manager - Public Markets
A: 12-24 Talavera Road, Macquarie Park NSW 2113

E: monica.jones@sanofi.com

W: www.astrazeneca.com.au

 

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible.  We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions.

Associate Sponsor & Exhibitor | AstraZeneca

AZ_CMYK_H_COL (002).jpg

Byron Nyin
Senior Brand Manager, Vaccines & Immune Therapies
A: 66 Talavera Road, Macquarie Park NSW 2113

E: immunity-anz@astrazeneca.com

W: www.astrazeneca.com.au

 

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in four therapy areas - Respiratory & Autoimmunity, Cardiovascular & Metabolic Disease, Oncology & Vaccines & Immune Therapies. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Associate Sponsor | Moderna

Moderna Logo.jpg

Belinda Anderson
Marketing Director
A: Level 49, 101 Collins Street Melbourne VIC 3000

E: belinda.anderson@modernatx.com

W: www.modernatx.com/en-AU

 

Moderna’s Mission is to deliver the greatest possible impact to people through mRNA medicines. The company was founded in 2010, focused on building the leading mRNA technology platform, infrastructure to accelerate drug discovery and early development, a rapidly expanding pipeline, and a world-class team. Our pipeline includes development candidates for mRNA-based vaccines and therapies spanning several therapeutic areas, with multiple clinical trials underway and other development candidates progressing toward the clinic. In addition, there are numerous discovery programs advancing toward development.

Exhibitor | National Centre for Immunisation Research & Surveillance

NCIRS-Hero-Logo-CMYK_NEW.jpg

Communication Officer
A: Locked Bag 4001, Westmead NSW 2145
E: SCHN-NCIRS@health.nsw.gov.au
W: www.ncirs.org.au

The National Centre for Immunisation Research and Surveillance (NCIRS) undertakes objective expert research and provides trusted advice, services and support to partners at local, national and international levels.

 

NCIRS's unique position and mandate as a national centre enables the organisation to have a wide ranging impact on vaccine preventable disease.

Tuesday Refreshment Break Sponsor & Exhibitor  |  University of Tasmania

UniTas_BM_H_Pos_Col_RGB_2021_2x.png

Associate Professor Nicola Stephens
Director, Public Health and Health Services Innovation
A: Private Bag 34, Hobart TAS 7000

E: SM-Health.Protection@utas.edu.au

W: www.utas.edu.au/health

 

The University of Tasmania’s (UTAS) Public Health program has developed a Graduate Certificate in Health Protection to upskill the public health workforce in infectious disease prevention and control. Nested into our Master of Public Health course, and compromising two new units of Outbreak Management and Public Health Surveillance that are also offered as short courses for workforce development, the UTAS Health protection offerings align to those working in communicable diseases and immunisation. Find out more about our suite of postgraduate courses in public health at www.utas.edu/study/public-health.

Affiliation Sponsor | The Peter Doherty Institure for Infection and Immunity

Consolidated JV Lock-up-CMYK Transparent.png

Jennifer Fagundes
Operations and Projects Co-ordinator
A: 792 Elizabeth Street, Melbourne VIC 3000

E: Doherty.reception@unimelb.edu.au

W: www.doherty.edu.au/

 

Finding solutions to prevent, treat and cure infectious diseases and understanding the complexities of microbes and the immune system requires innovative approaches and concentrated effort. This is why the University of Melbourne – a world leader in education, teaching and research excellence – and The Royal Melbourne Hospital – an internationally renowned institution providing outstanding care, research and learning – partnered to create the Peter Doherty Institute for Infection and Immunity (Doherty Institute); a centre of excellence where leading scientists and clinicians collaborate to improve human health globally.

Exhibitor  |  Vitavo

Vitavo_Logo_Primary_PNG_20x (1).png

Anthony Renehan

Ph 1300 068 463

E: info@vitavohealth.com

W: www.vitavohealth.com

 

Vitavo (formerly VaxApp) is a digital immunisation management platform that improves patient access and uptake of vaccinations. Vitavo is used by local governments, workplace health providers, pharmacies and medical centres across Australia. The platform supports immunisation providers to vaccinate more people, in less time and with less cost. Vitavo's modular approach tailors the patient journey and clinical workflow to the vaccination program delivery models across community clinics, schools, workplaces, aged care and pharmacies.

Vitavo developed and engineered the world’s first automated immunisation eligibility engine which utilises over 30 different patient data points (including demographics, indigenous status, medical conditions, birth weight/gestation information, vaccination history and more) to generate suggested eligible vaccines for a patient. The engine also functions to prompt eligibility of additional vaccines which may include paid vaccines or vaccines funded under national or state immunisation schedules based on specific profile data points. The system is automated to trigger communication recalls and reminders for all eligible vaccines throughout a patient’s lifetime based on their specific medical profile. 

Exhibitor  |  Australian National University

Dr Emma Field
Director, Master of Philosophy in Applied Epidemiology (MAE)
A: 62 Mills Road, Acton ACT 2601

E: mae.nceph@anu.edu.au

W: www.anu.edu.au

The Master of Philosophy (MPhil) in Applied Epidemiology is a 22-month program that trains internationally accredited future public health leaders. Using an ‘on-the-job’ approach, students spend most of the program working within field placements. This supports capacity development in the health sector and ensures our alums gain real-life training contributing to the detection, investigation, response and control of acute public health events. Scholars also undertake short periods of intensive coursework and complete a research thesis. In addition, students can participate in an internship at WHO during their study to apply their learning in an international context.

Exhibitor  |  Vaxxas

logo_639x132_042f64.png

Elke Hacker
Senior Research Scientist
A: 240 MacArthur Ave, Hamilton QLD 4007

E:  info@vaxxas.com

W: www.vaxxas.com

Vaxxas is a privately held biotechnology company focused on enhancing the performance of existing and next-generation vaccines with its proprietary high-density, microarray patch (HD-MAP). Vaxxas uses proprietary dry-coating technology to apply an active and stable vaccine onto the projections, which offers the potential to eliminate the need for vaccine refrigeration during storage and transportation. Vaxxas is working towards improving access to vaccines in hard-to-reach areas by simplifying vaccine distribution and administration.

Exhibitor  |  ASHM Health

ASHM_logo_RGB.png

Exhibitor  |  Public Health Association of Australia

Skye O'Halloran
Project Officer
A: Level 7, 243 Edward Street, Brisbane QLD 4000

W: www.ashm.org.au

ASHM represents healthcare professionals in HIV, BBV, and sexual and reproductive health. We partner and collaborate to enhance workforce capacity and strengthen health systems to address stigma and barriers to care.

As a trusted community of practice, we provide resources, training, conferences, and advocacy. Join us in eliminating harm, improving wellbeing, and protecting diverse communities.

PHAALogo.png

PHAA Team
A: Unit 2 / 20 Napier Close, Deakin ACT 2600

E: phaa@phaa.net.au

W: www.phaa.net.au

 

The Public Health Association of Australia (PHAA) is recognised as the principal non-government organisation for public health in Australia working to promote the health and well-being of all Australians. It is the pre-eminent voice for the public’s health in Australia. The PHAA works to ensure that the public’s health is improved through sustained and determined efforts of the Board, the National Office, the State and Territory Branches, the Special Interest Groups
and members.
The efforts of the PHAA are enhanced by our vision for a healthy Australia and by engaging with like-minded stakeholders in order to build coalitions of interest that influence public opinion, the media, political parties and governments.

Destination Supporter

327503-brisbane-australia-wordmark-black.jpg

Level 20, 69 Ann Street, Brisbane Qld 4000 Australia

PO Box 12260, George Street, Brisbane Qld 4003 Australia

beda.brisbane.qld.au

visit.brisbane.qld.au 

choose.brisbane.qld.au

bottom of page